News | May 15, 2015

iCAD Inc. Announces Information Related to Brachytherapy Reimbursement Levels

Company working with CMS to clarify new CPT code for electronic brachytherapy for non-melanoma skin cancers

iCAD, Medicare, resimbursement, CPT, brachytherapy, non-melanoma skin cancers

May 15, 2015 — iCAD Inc. announced that Noridian, the Medicare administrative contractor in Jurisdictions E and F, has made recent web postings related to Coding for High Dose Rate Brachytherapy for Non-Melanoma Skin Cancers. These postings instruct physicians to report CPT code (17999) rather than the established CPT code (0182T) for electronic brachytherapy for non-melanoma skin cancers. Jurisdictions E and F consist of 13 states primarily on the West Coast.

iCAD, industry partners and physician providers have reached out to the Centers for Medicare and Medicaid Services ("CMS") and Noridian to seek clarification of the Medicare Coverage Articles posted to Noridian's web sites.

The company is proactively addressing the situation in its dialogue with Noridian and CMS. At this point, there is insufficient clarification of the reimbursement matter to assess the potential impact that this matter could have on the company's guidance for 2015. Any significant changes in CPT reimbursement from current levels could have a material impact on iCAD’s revenues.

For more information: www.icadmed.com

Related Content

3 Recommendations to Better Understand HIPAA Compliance
Feature | Information Technology | May 17, 2019 | Carol Amick
According to the U.S.
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
ITN reached 90,000 unique Facebook users with content during the week of the visit to Central DuPage Hospital

ITN reached 90,000 unique Facebook users with content during the week of the visit to Central DuPage Hospital.

News | Radiology Business | May 10, 2019
Imaging Technology News (ITN) earned an Honorable Mention at the 2019 National Azbee Awards of Excellence in the Cross-...
The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core

The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core. Credit: Wenpei Fan, LOMIN Laboratory, NIBIB.

News | Radiation Therapy | May 08, 2019
Radiation kills tumors by creating oxygen free radicals that damage the tumor DNA. However, the lack of oxygen in the...
An illustration of radiology department analytics data showing GE Healthcare's business analytics software.
Feature | Radiology Business | May 03, 2019 | April Wilson
According to IBM, the world creates 2.5 quintillion bytes of data daily.